Sat.Nov 27, 2021 - Fri.Dec 03, 2021

article thumbnail

Hack targets Planned Parenthood, exposing personal information of 400K patients

Fierce Healthcare

Hack targets Planned Parenthood, exposing personal information of 400K patients. rtorrence. Fri, 12/03/2021 - 10:13.

145
145
article thumbnail

Digital health: the new normal?

pharmaphorum

Personalised and tailored healthcare that utilises patient’s data is rapidly becoming a reality. Ben Hargreaves looks at the concrete steps already being taken by companies in the area. Amongst the many ways in which the pandemic has changed the way in which we live, one of the most common experiences for most people was to revise what it means to have a face-to-face meeting.

145
145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Genetic testing offers powerful weapon for detecting breast cancer: Sema4

Outsourcing Pharma

A leader from the health tech solutions company explains how progress in genetic testing has helped advance the detection and prevention of breast cancer.

116
116
article thumbnail

GSK aim for HIV cure by 2030

Pharma Times

Following its recent approval of an injectable HIV-1 treatment from the National institute for Health and Care Excellence (NICE), GlaxoSmithKline (GSK) has high hopes in developing a cure for the virus in the future.

61
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

CVS inks tech partnership with Microsoft to accelerate its 'digital-first' strategy

Fierce Healthcare

CVS inks tech partnership with Microsoft to accelerate its 'digital-first' strategy. hlandi. Thu, 12/02/2021 - 06:26.

145
145
article thumbnail

Trial of Jazz’ cannabis drug in glioblastoma will start next year

pharmaphorum

An investigator-led trial of Jazz Pharma’s cannabis extract-based drug Sativex in glioblastoma – an aggressive form of brain cancer – will get underway in the UK next year. The three-year phase 2 trial will be carried out by researchers at Leeds University led by professor of clinical oncology and neuro-oncology Susan Short, and see if adding Sativex (nabiximols) to standard chemotherapy for recurrent glioblastoma can extend survival.

More Trending

article thumbnail

Late cancer diagnoses rise as NHS struggles with COVID-19

Pharma Times

Analyses provided by UK cancer charity Macmillan has provided insights into the repercussions experienced by patients waiting to receive treatment during the COVID-19 pandemic.

56
article thumbnail

Out-of-pocket costs may play larger role in telehealth visits than in-person care: survey

Fierce Healthcare

Out-of-pocket costs may play larger role in telehealth visits than in-person care: survey. rtorrence. Fri, 12/03/2021 - 16:07.

145
145
article thumbnail

Boehringer-backed digital health academy set for launch in UK

pharmaphorum

An online training academy that aims to raise the digital skills of NHS health and care workers is due to open its virtual doors next March, according to the Organisation for the Review of Care and Health Apps (ORCHA). The Digital Health Academy – developed with pharma company Boehringer Ingelheim – is part of a drive to get digital health tools and apps used more routinely in the management of health conditions, according to ORCHA.

121
121
article thumbnail

Decentralized format dramatically transforming clinical research: ICON

Outsourcing Pharma

An expert from the ]contract research organization discusses the impact virtual trials have had on the industry, and how that transformation is likely to continue.

105
105
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Possible identification of blood clot trigger for AstraZeneca COVID-19 vaccine

Pharma Times

Researchers have identified in those patients experiencing blood clots after vaccination a subsequent condition referred to as vaccine-induced immune thrombotic thrombocytopenia (VITT).

article thumbnail

Business Group: 6 health and wellness trends to watch in 2022

Fierce Healthcare

Business Group: 6 health and wellness trends to watch in 2022. pminemyer. Mon, 11/29/2021 - 12:17.

144
144
article thumbnail

MHRA okays GSK’s Xevudy as data suggest it works against Omicron

pharmaphorum

The UK medicines regulator has approved GlaxoSmithKline and Vir Biotech’s antibody for COVID-19, Xevudy, which has been shown to be effective against the new Omicron strain of SARS-CoV-2 in lab testing. Xevudy (sotrovimab) is the second COVID-19 antibody to be approved by the MHRA after Roche/Regeneron’s Ronapreve (casirivimab and imdevimab), which got a green light during the summer.

Vaccines 119
article thumbnail

GSK and University of Oxford launch new institute, embracing advanced technologies for drug discovery

Outsourcing Pharma

The Oxford-GSK Institute of Molecular and Computational Medicine has been created via a five-year collaboration between GlaxoSmithKline and the University of Oxford.

98
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

UK orders extra 114 million COVID-19 vaccines to combat Omicron

Pharma Times

Scientists and health experts have cautioned that the new variant could have the ability to bypass the effectiveness of vaccines that are currently available.

article thumbnail

Carbon Health launches new program with continuous glucose monitors to assess diabetes risk

Fierce Healthcare

Carbon Health launches new program with continuous glucose monitors to assess diabetes risk. rtorrence. Wed, 12/01/2021 - 17:47.

144
144
article thumbnail

AZ eyes FDA verdict on Lynparza in adjuvant breast cancer in Q1

pharmaphorum

The FDA will deliver a verdict on AstraZeneca’s PARP inhibitor Lynparza as an adjuvant treatment for breast cancer in the first quarter of next year, after granting the application a priority review. AZ and partner Merck & Co have filed Lynparza (olaparib) for use in BRCA-mutated, HER2-negative early breast cancer in patients who have already been treated with chemotherapy either before or after surgery and are at high risk of the disease coming back.

FDA 111
article thumbnail

Decentralized format can help elevate trial inclusivity: Science 37

Outsourcing Pharma

An expert from the decentralized clinical trial solutions provider discusses how the virtual format and technology can help improve study representation.

88
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Total UK cases of Omicron rise to nine

Pharma Times

An additional six cases of the Omicron variant have now been detected in Scotland, bringing the UK total so far to nine.

54
article thumbnail

Pandemic-era burnout, short-staffing has more nurses eyeing the door, survey says

Fierce Healthcare

Pandemic-era burnout, short-staffing has more nurses eyeing the door, survey says. dmuoio. Fri, 12/03/2021 - 14:22.

141
141
article thumbnail

Novartis takes aim at risky Parkinson’s target with $1.5bn UCB deal

pharmaphorum

Novartis has licensed a potential drug for Parkinson’s from Belgium’s UCB that it thinks could be the first oral, disease-modifying drug for the disease – if it can avoid the fate of earlier drugs in the class. The drug – called UCB0599 – targets a protein called alpha synuclein that tends to get misfolded and accumulates into clumps in the brains of Parkinson’s patients, and is thought to damage neurons – somewhat analogous to amyloid and tau proteins in Alzheimer’s dise

article thumbnail

AI-based blood analysis tool geared toward decentralized diagnostics

Outsourcing Pharma

With the release of its new Sight OLO artificial intelligence based blood analyzer, Sight Diagnostics hopes to offer DCTs reliable, easy-to-use testing.

82
article thumbnail

Up to 12 million people in England could face NHS waiting list crisis by 2025

Pharma Times

Amid the COVID-19 pandemic, the NHS faces staff and hospital equipment shortages alongside the growing need to reduce the backlog in patient surgeries and treatments.

article thumbnail

AMA: Medicare physician fee schedule spending dropped nearly $14B last year due to COVID-19

Fierce Healthcare

AMA: Medicare physician fee schedule spending dropped nearly $14B last year due to COVID-19. rking. Fri, 12/03/2021 - 12:25.

141
141
article thumbnail

Trial closes gap between Bayer’s Nubeqa and rivals in prostate cancer

pharmaphorum

Bayer’s Nubeqa is making headway as a treatment for castration-resistant prostate cancer (CRPC), but could be on track to expand the eligible patient population for the drug thanks to new phase 3 data. Just released results from the ARASENS trial show that adding Nubeqa (darolutamide) to docetaxel chemotherapy and androgen deprivation therapy (ADT) to switch off testosterone production helps men with castration-sensitive prostate cancer (CSPC).

article thumbnail

Decentralized trials dramatically transforming clinical research: ICON

Outsourcing Pharma

An expert from the contract research organization discusses the impact decentralized trials have had on the industry, and how that transformation is likely to continue.

64
article thumbnail

All adults to be offered COVID-19 booster jabs by end of January 2022

Pharma Times

The UK government has aimed to expand their COVID-19 vaccination programme, in accordance with guidance from the Joint Committee on Vaccination and Immunisation (JCVI).

article thumbnail

PCMA pulls lawsuit over rebate disclosure rule after reaching deal with Biden admin

Fierce Healthcare

PCMA pulls lawsuit over rebate disclosure rule after reaching deal with Biden admin. rking. Thu, 12/02/2021 - 16:20.

140
140
article thumbnail

15 traits of effective bosses and how to catalyse your team

pharmaphorum

Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. This post looks at people manager effectiveness and how to boost team and co-worker engagement. It’s that special time in the annual corporate lifecycle: year-end performance reviews are being conducted around the globe, employee ratings allocated, calibrated and translated into salary increa

article thumbnail

Automating safety processes can benefit DCTs: Pharmasol

Outsourcing Pharma

A leader from the pharmacovigilance solutions firm discusses the ins and outs managing safety documentation and offers advice on how to deal with them.

article thumbnail

NIHR study shows high efficacy of booster vaccines

Pharma Times

The news arrives after the tenth recorded positive Omicron case in Scotland, which the government has confirmed has no previous connection to the previous nine.

article thumbnail

HHS: Telehealth use in Medicare increased 63-fold last year with behavioral health increasing the most

Fierce Healthcare

HHS: Telehealth use in Medicare increased 63-fold last year with behavioral health increasing the most. rking. Fri, 12/03/2021 - 16:14.

137
137
article thumbnail

Health Innovators: Senseonics’ Francine Kaufman

pharmaphorum

In the most recent of the Health Innovators video series, pharmaphorum’s founder, Dr Paul Tunnah, chats with the chief medical officer of Senseonics. Francine Kaufman discusses how Senseonics is helping patients monitor their diabetes with the first fully implantable long-term continuous glucose monitoring (CGM) system. Monitoring glucose values is necessary for diabetes patients, and technologically advanced systems make it much easier for patients to self-manage the disease, according to

105
105